Rare Genetic Diseases with Human Lean and/or Starvation Phenotype Open New Avenues for Obesity and Type II Diabetes Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|14|13|1093-1098

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.13, 2013-01, pp. : 1093-1098

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 23, Iss. 5, 2017-03 ,pp. : 667-668

Bentham Science Publishers

Access to resources Recommend Favorite

Lean Times for Obesity Treatment

By  

Pharmaceutical Innovation, Vol. 11, Iss. 5, 2002-08 ,pp. : 21-22

Adis International

Access to resources Recommend Favorite

The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes

By Nelson Robert H   Miles John M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2483-2491

Informa Healthcare

Access to resources Recommend Favorite

Saxagliptin: A New Drug for the Treatment of Type 2 Diabetes

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 8, 2010-07 ,pp. : 759-765

Bentham Science Publishers

Access to resources Recommend Favorite

ATP Synthesis Revisited: New Avenues for the Management of Mitochondrial Diseases

By  

Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. : 4570-4579

Bentham Science Publishers

Access to resources Recommend Favorite